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Abstract:
5
 CD44 ligand-receptor interactions are known to be involved in regulating cell 
migration and tumor cell metastasis.
 High expression levels of CD44 correlate with poor prognosis of melanoma 
patients.
 The effect of DTIC treatment was quantified by the dynamic binding force
and the ligand-binding free-energy landscape.
 Atomic force microscopy-based nanoscopic methods offer thermodynamic 
and kinetic insight into the effect of DTIC on the CD44 ligand-binding 
process.
Introduction:
 CD44 ligand-receptor is important for
migration
adhesion
proliferation
Signal transduction
 Melanoma cells proliferation ,tumor progression , and 
metastasis are mediated by the interaction of CD44 ligand-
receptor. 
 Increased levels of CD44s &CD44v have been considered 
prognostic markers for disease progression.
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What is the effect if chemotherapeutic drug on 
CD44 expression?
• The alkylating agent dacarbazine (DTIC) is a major chemotherapeutic drug for 
the treatment of malignant melanoma but its efficacy is very disappointing
• the patients treated with DTIC, the tumor readily becomes resistant to the drug. 
Thus
Quantitative investigation of how and to what extent DTIC influences the binding 
strength of CD44 ligand –receptor may improve drug treatment efficacy. 
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o In this investigation , high resolution AFM imaging and 
nanoidentation-based soft colloidal force spectroscopy were used to 
detect real-time changes in melanoma cell morphology , 
nanostructure , nanomechanical properties before and after DTIC 
treatment.
o This was accomplished at the single-molecule level.
o All morphology images were obtained using AFM in contact mode.
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Material and methods:
CCK-8 assay to analyze cell viability 
9
Results 1:
 The cytotoxicity of DTIC to 
the melanoma cell line B16-
F10 was determined by 
CCK-8 assay.
 The IC50 value was 133.75 
microgram per milliliter.
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CD44 analysis by flow cytometry (FCM)
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Antibody-conjugated quantum dot (QD) fluorescence staining
The staining procedure for the CD44 antibody and QD 
conjugates was as follows: control cells and the cells treated with 
25, 50, and 75 μg/mL DTIC for 24 hours were washed with 
phosphate-buffered saline (PBS), then fixed with 2% 
formaldehyde at 4°C for 30 minutes, and then washed three 
times with PBS before staining. The cells were then blocked for 
30 minutes with 1% bovine serum albumin (BSA) and incubated 
with 20 mg/mL biotinylated anti-mouse CD44 antibody for 60 
minutes; next, the cells were incubated with 1 μg/mL QD-
streptavidin for 60 minutes in the dark. CD44 molecules were 
viewed using a LCM 510 Meta Duo laser scanning confocal 
microscope (LSCM) (Carl Zeiss Meditec AG, Jena, Germany).
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Immunofluorescence imaging of the cytoskeleton proteins , F-actin and tubulin
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Result 2:
 The quantitatively investigate 
the effect of DTIC on CD44 
expression.
 FCM was used to measure the 
levels of CD44 by B16-F10 
cells with and without DITC 
treatment.
 LSCM images were used to 
visualized the expression of 
CD44 on cells with or without 
DITC treatment.
 These data suggest that DTIC 
inhibits the expression of CD44 
with correspondence to changes 
in cell morphology. 
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 The CD44 is an organizer of the cortical actin skeleton that extracellularly binds 
to ligands in the ECM , and intracellularly , is mechanically linked to the actin 
cytoskeleton through erzin/radixin /moesin proteins.
 Signal transduction requires the cytoplasmic tail region of CD44 to interact with 
actin to link to the local cytoskeleton organization.
The investigation of the interaction CD44 and B16-F10 cytoskeleton before & after cell 
treatment with DTIC may contribute to an understanding of the treatment effect of DTIC 
on melanoma.
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AFM measurements: 
o All morphology images were obtained using AFM in contact mode .
o Real-time changes were investigated in the surface morphology and 
ultrafine structure of B16-F10 cells treated with DTIC using AFM.
o The cell membrane is an important regulator of cell function and 
changes in it can directly influence the normal functions of cells.
o The AFM images revealed remarkable differences in cell morphology  
and surface structure in presence and absence of DTIC.
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Changes in the 
morphological 
ultrastructure of 
a single B16-
F12 cell 
following DTIC 
treatment
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As shown in this 
figure , cell 
membrane were 
damaged and 
showed some 
umblications and 
particles enlarged 
and were 
heterogonous. 
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In order to quantify the fraction of cell membrane damaging induced by DTIC, 
release of lactate dehydrogenase (LDH) into the medium was measured.
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Alterations in the nano-biomechanical properties of cells treated with DTIC 
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So DTIC:
Inhibited the expression of CD44
Disrupted the local linkage of CD44 to 
the cytoskeleton
Triggering a decrease in cellular 
elasticity
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AFM nanoscale imaging of CD44 molecules using single-molecule 
force spectroscopy(SMFS)
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I. Unbinding forces were detected on the border and apical regions .
II. The unbinding force for the CD44 ligand-receptor decreased slightly after 
treatment with DTIC. 
III. The results of the AFM recognition experiment were consistent to the results 
of the LSCM and FCM assays.
IV. Treatment with different DTIC concentrations showed no significant decrease 
in CD44 unbinding force between CD44 ligand and receptor, while the CD44 
nanodomains were reduced and became smaller.
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Quantifying the change in kinetic and thermodynamic parameters
 After cells were treated with 25 and 75 micro molar per ml DTIC 
for 24 hours , the reconstructed CD44 ligand-binding free-energy 
decreased .
 These results demonstrate the CD44 ligand-receptor complexes on 
the surface of DTIC-treated melanoma cells to be less stable than 
those on the surface of untreated melanoma cells.
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Conclusion:
AFM was used to investigate 
the effect of DTIC on binding 
strength and free-energy 
landscape 
By using DTIC, new insights at 
the single molecule level were 
obtained for visual changes in 
CD44 nanodomain distribution 
and size
The CD44 ligand-receptor 
complexes on DTIC-treated cells 
were less stable than those on 
control cells
The dissociation constant 
increased and ligand-binding 
free-energy decreased when 
cells were treated 
DTIC perturbs the kinetic & thermodynamic 
interaction of CD44 ligand binding but does 
not completely inhibit the binding of the 
CD44 ligand to its membrane receptor 
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